Respiri - Telehealth acquisition to bolster US roll-out
In a strategic push of its US commercialisation strategy, Respiri has announced the proposed acquisition of Access Managed Services, its US remote...
230 Views
Respiri - Commercialisation at the forefront
Respiri released its Q323 activity report, updating investors on key highlights during the quarter. The period was marked by continued expansion of...
326 Views
Respiri - Wheezo commercialization picking up pace
In a recent business update, Respiri recapped its commercialisation efforts for the wheezo device and associated remote patient monitoring (RPM)...
182 Views
Respiri - Strong momentum heading into FY24
Respiri’s H123 report summarised an eventful period, marked by commercial traction (six client wins; patient onboarding commenced at four centres)...
210 Views
Respiri - wheezo included in paediatric standard of care
Respiri has announced the successful completion of the Michigan Children’s Hospital’s pilot programme assessing the wheezo SAAS (Respiri and...
208 Views